ProfileGDS5822 / ILMN_2749487
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 88% 90% 89% 88% 89% 88% 88% 88% 91% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1344.788
GSM1276600PDAC Late Ablation Control 2476.490
GSM1276601PDAC Late Ablation Control 3523.789
GSM1276602PDAC Late Ablation 1370.688
GSM1276603PDAC Late Ablation 2449.989
GSM1276604PDAC Late Ablation 3398.388
GSM1303940PDAC Late Ablation_anti-CTLA4 1389.488
GSM1303941PDAC Late Ablation_anti-CTLA4 244788
GSM1303942PDAC Late Ablation_anti-CTLA4 3668.191